Regenxbio (RGNX) FCF Margin (2014 - 2025)

Regenxbio (RGNX) recorded quarterly FCF Margin of 169.01% in Q4 2025, up 10.98% quarter-over-quarter from 189.86% in Q3 2025, and down 1485.0% on a YoY basis from 12.2% in Q4 2024.

Regenxbio (RGNX) FCF Margin (2014 - 2025) Analysis & Trends

Regenxbio's FCF Margin history runs 12 years deep, the most recent figure standing at 169.01% for Q4 2025.

  • In Q4 2025, FCF Margin fell 1485.0% year-over-year to 169.01%; the TTM figure through Dec 2025 stood at 73.25% (up 13743.0% YoY), while the FY2025 annual figure was 73.25%, up 13743.0% from the prior year.
  • FCF Margin was 169.01% for Q4 2025 at Regenxbio, up from 189.86% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 82.0% in Q4 2021 to a low of 447.99% in Q1 2023.
  • Historically, FCF Margin has averaged 207.21% across 5 years, with a median of 202.54% in 2021.
  • The sharpest annual moves came in 2022 and 2025: FCF Margin tumbled 22506 bps in 2022, then jumped 39518 bps in 2025.
  • A 5-year view of FCF Margin shows it stood at 82.0% in 2021, then plunged by 274 bps to 143.06% in 2022, then slumped by 32 bps to 188.57% in 2023, then gained by 18 bps to 154.16% in 2024, then declined by 10 bps to 169.01% in 2025.
  • The last three FCF Margin figures came in at 169.01% (Q4 2025), 189.86% (Q3 2025), and 232.84% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 43.35%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Regenxbio 315.11 Mn 85.04 Mn - -169.01%

Historic Data

Download Data
DateValue
Dec 31, 2025 -169.01%
Sep 30, 2025 -189.86%
Jun 30, 2025 -232.84%
Mar 31, 2025 36.63%
Dec 31, 2024 -154.16%
Sep 30, 2024 -168.93%
Jun 30, 2024 -206.19%
Mar 31, 2024 -358.55%
Dec 31, 2023 -188.57%
Sep 30, 2023 -175.85%
Jun 30, 2023 -249.78%
Mar 31, 2023 -447.99%
Dec 31, 2022 -143.06%
Sep 30, 2022 -209.36%
Jun 30, 2022 -217.42%
Mar 31, 2022 -301.01%
Dec 31, 2021 82.00%
Sep 30, 2021 -198.88%
Jun 30, 2021 -253.75%
Mar 31, 2021 -397.52%